Calendar ABIONYX Pharma

Equities

ABNX

FR0012616852

Market Closed - Euronext Paris 16:35:24 26/04/2024 BST 5-day change 1st Jan Change
1.024 EUR +0.59% Intraday chart for ABIONYX Pharma -4.66% -20.50%

Chart calendar ABIONYX Pharma

59c.okAHCrR_VQQWqnFA8FB5s11HVv6Wng2-io7b4PI1rTE.9Bo-XtImIXVimz0opjIP_TRqELbbq37X_ODpqaBvm1uaOE9FxzsvcHDjHg~5b71551c4dcd1f294c50da641ca01971

Upcoming events on ABIONYX Pharma

15/05/2024 Q1 2024 Sales and Revenue Release
21/08/2024 Q2 2024 Sales and Revenue Release
25/09/2024 Q2 2024 Earnings Release
13/11/2024 Q3 2024 Sales and Revenue Release
17/03/2025 Q4 2024 Earnings Release (Projected)
24/09/2025 Q2 2025 Earnings Release (Projected)
16/03/2026 Q4 2025 Earnings Release (Projected)
23/09/2026 Q2 2026 Earnings Release (Projected)

Past events on ABIONYX Pharma

11/03/2024 06:30 Q4 2023 Earnings Release
28/02/2024 Q4 2023 Sales and Revenue Release
15/11/2023 Q3 2023 Sales and Revenue Release
03/11/2023 14:00 American Society of Nephrology Kidney Conference - Poster No: FR-PO1818
02/11/2023 20:30 American Society of Nephrology Kidney Conference - Poster No: TH-OR080
02/11/2023 14:00 American Society of Nephrology Kidney Conference - Poster No: TH-PO1158
26/09/2023 19:00 Q2 2023 Earnings Release
16/08/2023 Q2 2023 Sales and Revenue Release
16/05/2023 Q1 2023 Sales and Revenue Release
29/03/2023 17:48 Q4 2022 Earnings Release
28/02/2023 17:41 Q4 2022 Sales and Revenue Release
16/11/2022 Q3 2022 Sales and Revenue Release
29/09/2022 18:39 Interim 2022 Earnings Release
17/08/2022 Interim 2022 Sales and Revenue Release
19/05/2022 17:00 Q1 2022 Sales and Revenue Release
28/04/2022 17:17 FY 2021 Earnings Release
24/02/2022 17:00 FY 2021 Sales and Revenue Release
03/11/2021 Q3 2021 Sales and Revenue Release
09/09/2021 17:45 Interim 2021 Earnings Release
04/08/2021 Interim 2021 Sales and Revenue Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR
Released
Forecast
Spread
0,20
0,00
-
0,00
0,00
-
0,00
0,00
-
0,70
0,70
0%
5,30
2,65
100%
4,60
4,60
0%
EBITDA
Million EUR
Released
Forecast
Spread
-7,01
-6,25
-12.21%
-2,51
-5,87
57.19%
-2,95
-7,30
59.64%
-5,83
-3,00
-94.43%
0,00
-5,44
-
0,00
-4,00
-
EBIT
Million EUR
Released
Forecast
Spread
-7,10
-5,57
-27.54%
-2,50
-5,87
57.39%
-3,00
-7,30
58.9%
-5,95
-3,25
-83.14%
-4,11
-5,74
28.38%
-3,40
-4,60
26.09%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-6,31
-5,74
-9.78%
1,89
-3,60
152.42%
-1,89
-6,60
71.42%
-5,82
-3,30
-76.42%
0,00
-6,04
-
0,00
0,00
-
Net income
Million EUR
Released
Forecast
Spread
-6,30
-5,45
-15.6%
1,80
-0,59
402.77%
-1,90
0,00
-
-5,82
-3,40
-71.24%
-4,21
-5,82
27.76%
-3,50
-4,70
25.53%
EPS
EUR
Released
Forecast
Spread
-0,34
-0,31
-10.54%
0,09
-0,19
147.94%
-0,08
-0,35
77.03%
-0,23
-0,14
-66.52%
0,00
-0,22
-
0,00
-0,14
-
Announcement Date24/01/1910/03/2025/02/2128/04/2229/03/2311/03/24

Quarterly results

Fiscal PeriodDecember 2019 S1 2023 S1
Net sales
Million EUR
Released
Forecast
Spread
0,00


2,13


EBIT
Million EUR
Released
Forecast
Spread
-1,45





Net income
Million EUR
Released
Forecast
Spread



-2,25


Announcement Date06/09/1926/09/23

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ABNX Stock
  4. Calendar ABIONYX Pharma